Evidence map›Paper›PMID 37355913›Full record

SynthesisJournal of Parkinson's disease2023

Cross-Cultural Differences in Stigma Associated with Parkinson's Disease: A Systematic Review.

Ahmet Veli Karacan, Sema Nur Kibrit, Merve Koç Yekedüz, Neslihan Doğulu, Gorkem Kayis, Elif Yüsra Unutmaz, Talha Abali, F Tuba Eminoğlu, M Cenk Akbostancı, Rezzak Yilmaz

Open access · diamondAbstract readSystematic Review
In one paragraph

Synthesis in Journal of Parkinson's disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Determinants and progression of stigma in amyotrophic lateral sclerosis/motor neuron disease.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025
    Article
  8. Cognitive impairment in Parkinson's disease and other parkinsonian syndromes.Journal of neural transmission (Vienna, Austria : 1996) · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Tackling Parkinson's Disease as a Global Challenge.Journal of Parkinson's disease · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ahmet Veli KaracanAnkara University School of Medicine, Ankara, Turkey.
Sema Nur KibritAnkara University School of Medicine, Ankara, Turkey.
Merve Koç YekedüzDepartment of Pediatric Metabolism, Ankara University School of Medicine, Ankara, Turkey.
Neslihan DoğuluDepartment of Pediatric Metabolism, Ankara University School of Medicine, Ankara, Turkey.
Gorkem KayisAnkara University School of Medicine, Ankara, Turkey.
Elif Yüsra UnutmazDepartment of Neurology, Ankara University School of Medicine, Ankara, Turkey.
Talha AbaliAnkara University School of Medicine, Ankara, Turkey.
F Tuba EminoğluDepartment of Pediatric Metabolism, Ankara University School of Medicine, Ankara, Turkey.
M Cenk AkbostancıDepartment of Neurology, Ankara University School of Medicine, Ankara, Turkey.
Rezzak YilmazDepartment of Neurology, Ankara University School of Medicine, Ankara, Turkey.
Ankara University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStigma is an important social attitude affecting the quality of life (QoL) of people with Parkinson's disease (PwP, PD) as individuals within society.

objectiveThis systematic review aimed to 1) identify the factors associated with stigma in PD and 2) demonstrate culture-based diversity in the stigmatization of PwP. We also reported data from the Turkish PwP, which is an underrepresented population.

methodsFollowing the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement, a literature search of the PubMed/Medline electronic database was performed covering the last 26 years. Articles on self-perceived stigma in PD with a sample size >  20 and quantitative results were included. Data were extracted by independent reviewers.

resultsAfter screening 163 articles, 57 were eligible for review, most of which were from Europe or Asia. Only two studies have been conducted in South America. No study from Africa was found. Among the 61 factors associated with stigma, disease duration, sex, and age were most frequently studied. A comparison of the investigated factors across the world showed that, while the effect of motor impairment or treatment on stigma seems to be culture-free, the impact of sex, education, marriage, employment, cognitive impairment, and anxiety on stigma may depend on culture.

conclusionThe majority of the world's PD population is underrepresented or unrepresented, and culture may influence the perception of stigma in PwP. More diverse data are urgently needed to understand and relieve the challenges of PwP within their society.

Indexed as

Cognitive DysfunctionParkinson DiseaseCross-Cultural ComparisonEuropeHumansQuality of LifeParkinson’s diseasequality of lifestereotypingstigma

Identifiers

PMID37355913
PMCPMC10473089
OpenAlexW4381429974

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.